Understanding Pituitary Tumors,
from diagnosis to care
Pituitary tumors (pituitary neuroendocrine tumors, PitNETs) are among the most common intracranial tumors. Most are benign and treatable, but require careful endocrine and neurosurgical management.
New Pituitary Tumor Cases per Year (U.S.)
Diagnosis combines imaging, pathology, and molecular features to guide care.
Most plans combine surgery, radiation, systemic therapy, and ongoing supportive care.
What is pituitary tumors, and how is it classified?
The subtypes below summarise how this condition is classified in modern neuro-oncology — each behaves differently and is treated differently.
Prolactinoma
Most common functioning pituitary tumor (~40%). Secretes prolactin. Usually responds to dopamine agonist medical therapy without surgery.
GH-secreting (Acromegaly)
Causes acromegaly in adults, gigantism in children. Somatotroph lineage (PIT1+). Treated with surgery and somatostatin analogs.
ACTH-secreting (Cushing Disease)
Causes hypercortisolism. Often microadenomas (<10mm). Corticotroph lineage (TPIT+). Transsphenoidal surgery is first-line.
TSH-secreting
Rarest functioning adenoma (<1%). Causes central hyperthyroidism. Thyrotroph lineage. Surgery and somatostatin analogs.
Nonfunctioning Pituitary Adenoma
Clinically silent, no hormone excess. ~30% of pituitary tumors. Presents with mass effect (visual field defects, headache).
Craniopharyngioma
Not a true pituitary adenoma. Adamantinomatous (CTNNB1 mutation) or papillary (BRAF V600E). Arises from Rathke pouch remnants.
Aggressive/Carcinoma
Rare aggressive PitNETs with rapid growth, invasion, or resistance to standard therapy. Temozolomide is key treatment.
The biomarkers that define your tumor
Modern classification depends on specific molecular markers — each revealing something different about the tumor and its likely behaviour.
Hotspot mutations in ~40% of corticotroph adenomas (Cushing disease). Activates EGFR signaling.
Cushing diseaseActivating mutations (McCune-Albright) in ~40% of GH-secreting adenomas. Constitutive cAMP signaling.
AcromegalyGermline mutations cause MEN1 syndrome: pituitary, parathyroid, and pancreatic tumors. Screen family members.
MEN1 syndromeGermline mutations cause familial isolated pituitary adenoma (FIPA). Young-onset, often GH-secreting.
FIPA syndromeDefines papillary craniopharyngioma. Potential target for BRAF/MEK inhibitor therapy (vemurafenib+cobimetinib).
Papillary cranioMutations define adamantinomatous craniopharyngioma. Nuclear accumulation on IHC. Distinct from papillary subtype.
AdamantinomatousExpressed in GH, PRL, and TSH lineage tumors. Key for pituitary adenoma lineage classification.
Lineage markerExpressed in corticotroph lineage. Defines ACTH-secreting adenomas and silent corticotroph tumors.
CorticotrophHow pituitary tumors can present
Symptoms vary by tumor location and size. This is general information — only your care team can interpret your situation.
Visual Field Defects
Bitemporal hemianopia from optic chiasm compression. Most common presenting symptom of large nonfunctioning adenomas.
Headache
Sellar/parasellar pressure. Can be severe with apoplexy (hemorrhage into tumor).
Hormonal Excess
Acromegaly features (GH), Cushingoid features (ACTH), galactorrhea/amenorrhea (prolactin), hyperthyroidism (TSH).
Hypopituitarism
Deficiency of one or more anterior pituitary hormones from compression of normal gland.
Diabetes Insipidus
Rare with adenomas; more common with craniopharyngioma or postoperatively. Excessive thirst and urination.
Pituitary Apoplexy
Acute hemorrhage or infarction: sudden headache, visual loss, ophthalmoplegia. Neurosurgical emergency.
Treatment options for Pituitary Tumors
Treatment depends on tumor type, grade, location, and overall health. Most plans combine several approaches.
Transsphenoidal Surgery
Endoscopic endonasal approach is standard. High cure rates for microadenomas. Preserves pituitary function in experienced hands.
Dopamine Agonists
First-line for prolactinoma: cabergoline or bromocriptine. Normalizes prolactin and shrinks tumor in >90% of cases.
Somatostatin Analogs
Octreotide LAR, lanreotide for acromegaly. Normalize IGF-1 in ~50-70%. Tumor shrinkage in ~20-30%.
Radiation Therapy
SRS (Gamma Knife) or fractionated for residual/recurrent tumors. Hormonal normalization over years.
Temozolomide
For aggressive pituitary tumors and carcinomas. MGMT methylation predicts response. 6-month trial standard.
Clinical Trials
Immunotherapy, targeted agents (BRAF/MEK for craniopharyngioma), and novel medical therapies under investigation.
Your multidisciplinary care team
Care is delivered by a team — specialists who diagnose and treat, and those who protect day-to-day quality of life.
Neurosurgeon
Performs brain or spine surgery for tumor removal or biopsy.
Best for: resection strategy, biopsy decisions, and surgery-related risk.
Neuro-oncologist
Brain-tumor specialist who leads treatment planning.
Best for: integrating pathology, imaging, medication, and trial options into one plan.
Radiation oncologist
Plans and delivers precision radiation therapy.
Best for: dose planning, side effects, and timing around surgery or systemic therapy.
Nurse navigator
Guides you through appointments, insurance, and logistics.
Best for: referrals, scheduling, records, and getting the right people in the room.
Oncology nurse
Day-to-day care coordination and symptom management.
Best for: new symptoms, medication questions, and urgent care coordination.
Mental health
Psychological support for patients and caregivers.
Best for: coping with uncertainty, caregiver strain, and adjustment after diagnosis.
You are not alone
These organisations provide information, community, and support for brain & spine tumor patients and caregivers.
Pituitary Network Association
Dedicated to pituitary tumor patient support, education, and advocacy for improved treatment.
Visit site ResourceCushing's Support & Research Foundation
Specifically supporting Cushing disease and syndrome patients with resources and research.
Visit site ResourceAcromegaly Community
Support and resources for acromegaly patients and families navigating treatment and follow-up.
Visit site ResourceNational Brain Tumor Society
Leading nonprofit investing in research, advocacy, and patient services for all brain tumors.
Visit site
Ready to explore clinical trials?
Search clinical trials for pituitary tumors and find the ones that match your specific diagnosis and hormone profile.
Find clinical trials